← Eichor
Study identifier: NCT05209841 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Heparinization vs Salinization of the Peripheral Venous Catheter

Condition: Catheter Complications  ·  Sponsor: Consorci Sanitari de l'Alt Penedès i Garraf

PhaseNA
Planned participants3450
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

Randomized, double-blind clinical trial to compare the efficacy of catheter sealing with saline, compared to low-dose heparin. 3,450 patients hospitalized at the Hospital Residencia Sant Camil, in Catalonia (Spain), will be randomized to each branch of study. The primary outcome will be the percentage of catheters removed due to obstruction in each branch of study. As secondary outcomes, the number of catheter-associated phlebitis, catheter-associated bacetrihemia, extravasation, and catheter loss will be measured. For the primary outcome, a superiority analysis will be carried out in terms of the percentage of obstructed catheters in each branch of the study.

This description comes directly from the study's public registry record.

Talk to the study team

Esther Moreno Rubio  ·  938960025  ·  emoreno@csapg.cat

Noemí Casaponsa  ·  +34 938960025  ·  recerca@csapg.cat

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital Residència Sant CamilSant Pere de Ribes, Barcelona, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05209841